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Abstract 
Liver markers indicate liver disorders that could be caused by drugs and infection such as hepatotropic viruses or 
its co-infection with HIV. Standard antiretroviral therapy (ART) consists of the combination of at least three 
antiretroviral (ARV) drugs to maximally suppress the HIV virus and stop the progression of HIV disease. This 
study was designed to determine the effect of antiretroviral therapy in co-infection of HIV with hepatitis B virus 
on serum ALT, GGT and LDH. Seventy six patients aged 16-65years including 50 HIV mono-infected and 26 
HIV-HBV patients that have not initiated antiretroviral therapy were recruited from Federal Medical Centre, 
Owo-Nigeria. Viral serological study of the patients were carried out by ELIZA and Immunoblotting. LDH, 
GGT and ALT were determined biochemically by Spectrophotometry. The results obtained showed a 
significantly higher mean values of LDH, GGT and ALT in the HIV-mono-infected after drug administration 
(334.4 ± 11.2, 24.9 ± 2.3, and 42.4 ± 1.1) than the results (296.5 ± 7.4; 14.8 ± 1.4 and 27.8 ± 1.7) of the 
parameters obtained before the initiation of the drug with p <0.05. There was a significantly higher mean values 
of LDH and ALT in the HIV patients co-infected with HBV before drug administration 440.3 ± 8.2 and 52.3 ± 
0.5 ) than the results (288.3 ± 5.7 and 36.6 ± 0.6) of the parameters  obtained after the initiation of the drug with 
p<0.05. However, there was a significantly lower mean value of GGT in the HIV-HBV patients before drug 
administration than after the initiation of the antiretroviral drug (p<0.05). This work revealed a significant 
increase in the values of LDH, GGT and ALT in the HIV-mono-infected patients after antiretroviral drug 
administration and in HIV-HBV patients before antiretroviral therapy. A significantly lower mean value of GGT 
in the HIV-HBV patients before drug administration than after the initiation of the antiretroviral drug. Evaluation 
of liver biomarkers in the treatment of HIV mono-infected and HIV-HBV patients is essential to avoid liver 
disorder and possible complications. 
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Introduction 
Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) infections are common among HIV positive patients in 
our environment and rapid detection and investigation  of these co-infections may attract better management to 
avoid complications such as liver cirrhosis, hepatocellular carcinoma, and thrombocytopenia (Obi et al., 2014). 
Patients with HIV infection are treated with a combination of antiretroviral medications to control their 
HIV infection. Several of these drugs are associated with liver enzyme elevations (Bonacini et al., 2002).On the 
other hand, the use of HAART has resulted in profound and durable HIV suppression, so that progression to 
AIDS and the occurrence of opportunistic infections has declined in regions where HAART is readily available. 
As a corollary, several liver diseases (chiefly HCV or HBV infection) have become more important in terms of 
morbidity and mortality in patients with HIV infection (Bonacini et al., 2000).  
Damage to the liver cell cytoplasmic membrane that may be caused by inflammation or leakage of 
cytoplasmic contents causes a relatively greater increase in the serum ALT than AST level (Wood et al., 
2003).On the other hand, if the damage occurs in both the mitochondria and cytoplasmic membrane, there is a 
proportionally greater increase in both the serum AST and ALT levels. Hence, AST and ALT are referred to as 
the Markers of hepatocellular damage. (Havlir et al., 2003)  
LDH is often measured in HIV patients as a non-specific marker for pneumonia due to Pneumocystis 
jiroveci (PCP). Elevated LDH in the setting of upper respiratory symptoms in an HIV patient suggests, but is not 
diagnostic for PCP. (Butt et al., 2002). 
GGT is predominantly used as a diagnostic marker for liver disease in medicine, latent elevations in 
GGT are typically seen in patients with chronic viral hepatitis infections often taking 12 months or more to 
present. (Lim et al., 2007). Elevated serum GGT activity can be found in diseases of the liver, biliary system, and 
pancreas. In this respect, it is similar to alkaline phosphatase (ALP) in detecting disease of the biliary tract. This 
study was designed to examine the effect of antiretroviral therapy on the biochemical changes caused by co-
infection of HIV with hepatitis B virus to provide useful information in the management of co-infection of HIV 
with hepatitis B virus. 
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Materials and Method 
Study area   
This study was carried out in Federal Medical Centre, Owo. Owo, is situated at the south-western Nigeria and is 
located at 7.1962 [latitude in decimal degrees], 5.58681 [longitude in decimal degrees] at an elevation/altitude of 
meters. The average elevation of Owo is 348 meters. The population of Owo is 276574. 
 
Sample size 
Sample size was determined by the formula 
N=4pq/12  
Where, 
N=sample size 
P=prevalence of HIV co infection with hepatitis B and C in Nigeria.(4%=0.04) 
Q=1-p (1-0.04=0.96) 
1=permissible error (5% of p=0.05)  
N=4x0.04x0.96/0.05x0.05=61.44. 
N=60 samples  
 
Study Population    
Patients confirmed to be seropositive for human immunodeficiency Virus (HIV) infection by Western blot 
technique were recruited for the study which include 38(50%) males; 38(50%) females; 50 HIV monoinfected, 
26(33.3%) HIV-HBV coinfected subjects aged 16 to 65 years.  
After the baseline sampling the confirmed HIV positive patients were allowed to be placed on highly active 
antiretroviral therapy (HAART) regimes of the APIN PEPFAR program of the institution. The choice of drug 
combination administered to each patient will be within the jurisdiction of the clinician and all the patients were 
followed up for two months. Worthy of note is that different drug combination is administered to patients co-
infected with either HBV or HCV.   
 
Inclusion criteria 
The test subjects included HIV monoinfected and co-infected HIV patients with HBV that are yet to initiate 
antiretroviral therapy were recruited and monitored before and after the administration of antiretroviral drugs. 
Both sexes were included within the age of 16 – 65 years. 
 
Exclusion criteria 
Patients who are seronegative to HIV regardless of whether they are anti-HCV or HBsAg seropositive were not 
studied as test. HIV patients that were under antiretroviral therapy were not included.  
 
Sample Collection and Preparation 
Five millilitre (5ml) volume of venous blood was obtained from each of the  test subjects before and after the 
initiation of antiretroviral therapy into a plain bottle for the extraction of serum to be used for biochemical assay.   
Blood samples were collected by clean venepuncture from the antecubital fossa into the already labelled plain 
test tubes, without undue pressure on either the arm or the plunger of the syringe. 
The samples were allowed to clot and were centrifuged at 3000 rpm to obtain the sera. The separated clear sera 
were transferred into sterile bottles and were used for the enzyme assay. When not used immediately, they were 
stored at –20°C and later used within five days. 
 
Hepatitis B Testing (Using QuickProfile HBsAg test) 
TEST PRINCIPLE: 
QuickProfile HBsAg Test is a double antibody sandwich immunoassay. Colloidal gold conjugated anti- HBsAg 
antibody complexes are dry immobilized in the test device. When the sample is added, it migrates by capillary 
diffusion through the strip re-hydrating the gold conjugate complexes forming particles. These particles will 
continue to migrate along the strip until the Test Zone (T) where they are captured by anti-HBsAg antibodies 
immobilized there and a visible red line appears. If there is no HBsAg in sample, no red line will appear in the 
Test Zone (T). The gold conjugate complexes will migrate alone until they are captured in the Control Zone (C) 
by immobilized goat anti-mouse IgG antibody aggregating a red line, which indicates the validity of the test. 
(Sehulster, 1981). 
 
LABORATORY ANALYSIS  
GAMMA GLUTAMYL TRANSFERASE 
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METHOD: ENZYMATIC METHOD (Using randox kit) 
PRINCIPLE: The substrate L-γ-glutamyl-3-carboxy-4-nitroanilide, in the presence of glycylglycine is converted 
by γ-GT in the sample to 5-amino-2-nitrobenzoate which can be measured at 405nm. (Szasz, 1969). 
L-γ-glutamyl-3-carboxy-4-nitroanilide + glycylglycine 
 γ-GT   
L-γ-glutamylglycylglycine + 5-amino-2-nitrobenzoate 
The coloured solution is measured using a spectrophotometer with a wavelength capability of 400 – 420nm. 
CALCULATION 
The GGT activity was calculated using the formula: 
U/L = 1158 ×    A 405 nm/min 
 
 
 
LACTATE DEHYDROGENASE 
METHOD: ENZYMATIC METHOD (Using Agappe kit) 
PRINCIPLE: Kinetic determination of lactate dehydrogenase according to the following reaction. (Wei Bhaar, 
1975) 
Pyruvate + NADH + H+                           L-lactate + NAD+ 
CALCULATION 
LDH-P activity (U/L) = (   OD/min) × 16030. 
 
3.6 3 ALANINE AMINOTRANSFERASE (SGPT) 
METHOD: ENZYMATIC METHOD (Using Agappe kit) 
PRINCIPLE 
Kinetic determination of Alanine Aminotransferase (ALAT) according to the following reaction. (Expert panel 
on enzyme of the IFCC, 1976) 
L-Alanine + a-ketoglutarate       ALT        Pyruvate + L- Glutamate  
Pyruvate + NADH + H+          LDH       L-Lactate + NAD+ 
CALCULATION 
ALT activity (U/L) = (     OD/min) ×1768 
3.8 STATISTICAL ANALYSIS      
Statistical package for social science (SPSS) version 17 was used. Statistical comparison between HIV mono-
infections, co-infections and each biochemical parameters was performed by ANOVA (one way). Data was 
presented as mean (x) and standard error of mean (SEM). The level of significance was taken at 95% confidence 
interval and P value less than 0.05 will be considered significant.    
 
Results 
TABLE 4.1: INFLUENCE OF ANTIRETROVIRAL THERAPY ON SOME LIVER BIOMARKERS IN 
HIV MONOINFECTED SUBJECTS 
Showing Mean ± Standard error of mean, t-value, p- value and remark. 
 
 
PARAMETERS 
 
BASELINE 
(Mean±SEM) 
 
AFTER DRUG 
ADMINISTRATION 
(Mean±SEM) 
 
 
T-VALUE 
 
 
P-VALUE 
 
 
REMARK 
          
         LDH 
        (U/L) 
296.5 ± 7.4 334.4 ± 11.2 2.986970 0.002101 Significant 
          
         GGT 
        (U/L) 
14.8 ± 1.4 24.9 ± 2.3 3.407312 0.000617 Significant 
        
         ALT 
        (U/L) 
27.8 ± 1.7 42.4 ± 1.1 7.693382 0.00001 Significant 
There was a significantly higher mean values of LDH, GGT and ALT in the HIV-mono-infected after drug 
administration (334.4 ± 11.2, 24.9 ± 2.3), and 42.4 ± 1.1) than the results (296.5 ± 7.4; 14.8 ± 1.4 and 27.8 ± 1.7) 
of the parameters obtained before the initiation of the drug with p <0.05. 
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4.2: INFLUENCE OF ANTIRETROVIRAL THERAPY ON SOME LIVER BIOMARKERS IN HIV - 
HBV COINFECTED SUBJECTS 
Showing Mean ± standard error of mean, t- value, p- value and remark. 
PARAMETERS BASELINE 
(Mean±SEM) 
AFTER DRUG 
ADMINISTRATION 
(Mean±SEM) 
T-VALUE P-VALUE REMARK 
          LDH 
         (U/L) 
440.3 ± 8.2 288.3 ± 5.7 -14.882078 ˂0.00001 Significant 
          GGT 
         (U/L) 
23.0 ± 2.2 26.3 ± 1.0  2.013984 0.024457 Significant 
          ALT 
        (U/L) 
52.3 ± 0.5 36.6 ± 0.6 -22.610385 ˂0.00001 Significant 
There was a significantly higher mean values of LDH and ALT in the HIV patients co-infected with HBV before 
drug administration 440.3 ± 8.2 and 52.3 ± 0.5 ) than the results (288.3 ± 5.7 and 36.6 ± 0.6) of the parameters  
obtained after the initiation of the drug with p<0.05. However, there was a significantly lower mean value of 
GGT in the HIV-HBV patients before drug administration than after the initiation of the antiretroviral drug 
(p<0.05). 
 
Discussion, Conclusion and Recommendation 
Discussion 
The significantly higher mean values of LDH, GGT and ALT in the HIV-mono-infected after drug 
administration than the results of the parameters obtained before the initiation of the drug could be due to the fact 
that some of the drugs could be haemolytic causing blood cells destruction probably causing increase in LDH as 
destruction of cells could be indicated by raised LDH (Butt et al., 2002). In addition to this, increased 
concentration of liver biomarker such as GGT and ALT could be attributed to the fact that patients with HIV 
infection are treated with a combination of antiretroviral medications to control their HIV infection. Several of 
these drugs are associated with liver enzyme elevations. Drug-induced liver injury (DILI) is defined as the 
elevation of liver enzyme and/or bilirubin levels in association with the use of a medication or drug. The term 
“hepatotoxicity” may be misleading, especially in patients with HIV infection, because some of these events may 
not be directly caused by a toxic medication. Instead, acute viral hepatitis, reactivation of chronic hepatitis B 
virus (HBV) or hepatitis C virus (HCV) infection, and/or alcohol ingestion may all play a role in such events 
(Sulkowski et al., 2000). Of note, patients often receive alternative and complementary medicines in association 
with HAART, and several of these have been associated with clear-cut DILI (Lewis and Strom, 2002). 
There was a significantly higher mean value of LDH and ALT in the HIV patients co-infected with 
HBV before drug administration than the results of the parameters obtained after the initiation of the drug. This 
could be attributed to  acute viral hepatitis, reactivation of chronic hepatitis B virus (HBV) or hepatitis C virus 
(HCV) infection, increased destruction of cells and/or alcohol ingestion suppression of the cause of the infection  
upon the initiation of antiretroviral drugs (Sulkowski et al., 2000).  However, there was a significantly lower 
mean value of GGT in the HIV-HBV patients before drug administration than after the initiation of the 
antiretroviral drug in HIV-HBV patients. This is consistent with the reports of Idoko et al., (2014) on the impact 
of Hepatitis B Virus Infection on Human Immunodeficiency Virus Response to Antiretroviral Therapy in 
Nigeria. 
 
Conclusion 
This work showed a significant increase in the values of LDH, GGT and ALT in the HIV-mono-infected patients 
after antiretroviral drug administration and in HIV-HBV patients before antiretroviral therapy. A significantly 
lower mean value of GGT in the HIV-HBV patients before drug administration than after the initiation of the 
antiretroviral drug. 
 
Recommendation 
Evaluation of liver biomarkers in the treatment of HIV mono-infected and HIV-HBV patients is essential to 
avoid liver disorder and possible complications. 
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